Despite a Hold by Key Panel, Ono Sees Cachexia Drug Launch in April-September 2020

Ono President Gyo Sagara The review of Ono Pharmaceutical’s cancer cachexia treatment anamorelin hit a snag in August, with a key panel putting a hold on recommending its approval, but President Gyo Sagara believes that the company will be able...read more